COVID-19
Conditions
Brief summary
The study will be done in Hacettepe University Anesthesiology and Reanimation Intensive Care Unit. The investigators will accept COVID-19 diagnosed or suspected patients to the ICU. In the first day of hospitalization and after that once a week, the investigators will take blood samples from the patients to evaluate Coenzyme q10 levels. Our hypothesis is that there is a relationship between low coenzyme q10 levels and poor clinical outcome.
Interventions
weekly blood sample - coenzym q10 levels
Sponsors
Study design
Eligibility
Inclusion criteria
\-
Exclusion criteria
* being under the age of 18 * being pregnant * patient refusal
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| mortality | from the first day of hospitalization until the date of death from any cause | yes or no |
| duration of mechanical ventilation | from the first day of hospitalization and during ICU stay period | days |
| duration of vasopressor agent requirement | from the first day of hospitalization and during ICU stay period | days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| any organ failure | from the first day of hospitalization until the date of death from any cause or discharge from ICU | yes or no |
| hospital stay period | from the first day of discharge from ICU to ward until the date of death or discharge from the hospital | days |
| new thromboembolic event | from the first day of hospitalization until the date of death from any cause or discharge from ICU | yes or no |
| ICU stay period | from the first day of hospitalization until the date of death from any cause or discharge from ICU | days |
Countries
Turkey (Türkiye)